Premium
Mood stabilizer use in pregnancy not linked with selected adverse birth outcomes
Publication year - 2019
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30483
Subject(s) - medicine , pregnancy , mood , adverse effect , confounding , cohort , cohort study , obstetrics , medicaid , mood stabilizer , pediatrics , psychiatry , bipolar disorder , health care , genetics , biology , economics , economic growth
Exposure to anticonvulsant mood stabilizers or lithium in pregnancy was not found to be associated with selected adverse pregnancy outcomes or preterm birth in a cohort study examining Medicaid‐eligible patients. While exposure to each individual drug was found to be associated with an increased risk of such adverse outcomes, the associations were not apparent after adjustment for potential confounding factors.